Cybin is a promising value investment, with advanced clinical trials and strong institutional support, poised to disrupt mental health treatment. Read more here.
Dr Patricia Ares-Romero and Dr Martin Rosenzweig discuss treatment strategies for TRD, including alternative therapies and explain current barriers within the healthcare system that inhibit access.